However, as recommended by healthcare professionals and research shows, semaglutide should not be used by people who have a personal or family history of a rare type of thyroid cancer called medullary thyroid carcinoma (MTC)
There are a whole class of medications that are insulin sensitizers, so perhaps we can develop medications that will allow people to be sensitized to GLP-1s or find formulations of GLP-1, like the longer-acting versions, that avoid the GLP-1 resistance, she said
That number dropped from 16 in October 2025 after California, New Hampshire, Pennsylvania, and South Carolina eliminated obesity GLP-1 coverage largely due to state budget constraints
The same active ingredient powers Wegovy, which received FDA approval specifically for obesity treatment in 2021
Hydration tracking also helps you make sure you are replacing lost fluids on tough days
Frequently Asked Questions When will retatrutide be commercially available